ETF Series Solutions - Range Cancer Therapeutics ETF Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

What is the ownership structure of CNCR?
Owner Type	Number of Shares	Ownership Percentage
Institutions	126,333	100%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 14.5%.

Top 14 shareholders own 0% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
0%	Susquehanna International Group, LLP, Asset Management Arm	40,027	US$0	9.87%	no data
0%	The Colony Group, LLC	31,154	US$0	64.1%	0.01%
0%	Old Mission Capital, LLC, Asset Management Arm	16,319	US$0	0%	0.01%
0%	Morgan Stanley, Investment Banking and Brokerage Investments	13,351	US$0	280%	no data
0%	Royal Bank of Canada, Banking & Securities Investments	11,296	US$0	123%	no data
0%	Prospera Financial Services, Asset Management Arm	10,000	US$0	0%	no data
0%	UBS Asset Management AG	1,861	US$0	-2%	no data
0%	Blue Bell Private Wealth Management, LLC	723	US$0	-49.1%	no data
0%	Northwestern Mutual Wealth Management Company	598	US$0	0%	no data
0%	Realta Investment Advisors, Inc	539	US$0	0%	no data
0%	Advisor Group Holdings, Inc., Asset Management Arm	150	US$0	-95.2%	no data
0%	SOA Wealth Advisors, LLC	150	US$0	0%	no data
0%	NewEdge Advisors, LLC	100	US$0	0%	no data
0%	RBC Dominion Securities Inc., Asset Management Arm	65	US$0	0%	no data